AFT Pharmaceuticals Pty Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:AFT Pharmaceuticals Pty Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011790
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AFT Pharmaceuticals Pty Ltd (AFT Pharmaceuticals) is a manufacturer and distributor medical products. The company provides prescription and non-prescription products. Its products include moisturizers, calcium supplements, scalp ointments, eye drops, cracked heel creams, iron and folic acid tablets, stomach ache and pain treatment products, and cold and flu relief tablets, among others. It provides its products in the form of cream, drops, tablets, capsules, liquids, and gel. AFT Pharmaceuticals offers products for various therapeutic areas such as allergy, cold and flu, eye care, first aid, fungal nails, iron supplements, laxatives, pain management, and skin care. The company also provides pharmacy training services. It operaties in Australia and Malaysia. AFT Pharmaceuticals is headquartered in Sydney, New South Wales, Australia.

AFT Pharmaceuticals Pty Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AFT Pharmaceuticals Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AFT Pharmaceuticals Pty Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AFT Pharmaceuticals Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AFT Pharmaceuticals Pty Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
AFT Pharmaceuticals Pty Ltd, Medical Devices Deals, 2011 to YTD 2017 10
AFT Pharmaceuticals Pty Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
AFT Pharmaceuticals Pty Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
AFT Pharma Raises USD14 Million in Venture Financing 12
AFT Pharma Secures USD30 Million from Capital Royalty Partners 13
AFT Pharmaceuticals Secures USD53 Million in Venture Funding from Capital Royalty 14
Partnerships 15
Martindale Pharma Enters into Distribution Agreement with AFT Pharma 15
Licensing Agreements 16
AFT Pharma Enters into Licensing Agreement with Novaliq 16
Weifa Enters into Licensing Agreement with AFT Pharma 17
Acino Pharma Extends its Licensing Agreement with AFT Pharma 18
GNI Enters Into Licensing Agreement With AFT Pharma For Etuary 19
Equity Offering 20
AFT Pharma Raises USD0.7 Million in Share Purchase Plan 20
AFT Pharma Raises USD6.3 Million in Private Placement of Shares 21
AFT Pharma Plans to Raise USD21.8 Million in IPO 22
AFT Pharmaceuticals Pty Ltd – Key Competitors 23
AFT Pharmaceuticals Pty Ltd – Key Employees 24
AFT Pharmaceuticals Pty Ltd – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Nov 24, 2016: AFT H1 FY17 Results Announcement 26
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
AFT Pharmaceuticals Pty Ltd, Pharmaceuticals & Healthcare, Key Facts 2
AFT Pharmaceuticals Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AFT Pharmaceuticals Pty Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AFT Pharmaceuticals Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AFT Pharmaceuticals Pty Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
AFT Pharmaceuticals Pty Ltd, Medical Devices Deals, 2011 to YTD 2017 10
AFT Pharmaceuticals Pty Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
AFT Pharma Raises USD14 Million in Venture Financing 12
AFT Pharma Secures USD30 Million from Capital Royalty Partners 13
AFT Pharmaceuticals Secures USD53 Million in Venture Funding from Capital Royalty 14
Martindale Pharma Enters into Distribution Agreement with AFT Pharma 15
AFT Pharma Enters into Licensing Agreement with Novaliq 16
Weifa Enters into Licensing Agreement with AFT Pharma 17
Acino Pharma Extends its Licensing Agreement with AFT Pharma 18
GNI Enters Into Licensing Agreement With AFT Pharma For Etuary 19
AFT Pharma Raises USD0.7 Million in Share Purchase Plan 20
AFT Pharma Raises USD6.3 Million in Private Placement of Shares 21
AFT Pharma Plans to Raise USD21.8 Million in IPO 22
AFT Pharmaceuticals Pty Ltd, Key Competitors 23
AFT Pharmaceuticals Pty Ltd, Key Employees 24
AFT Pharmaceuticals Pty Ltd, Other Locations 25
AFT Pharmaceuticals Pty Ltd, Subsidiaries 25

★海外企業調査レポート[AFT Pharmaceuticals Pty Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Jura Energy Corp (JEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Jura Energy Corp (Jura Energy), formerly Proprietary Industries Inc., is an independent upstream company. It explores, develops and produces crude oil and natural gas from its assets in Pakistan. The company undertakes upstream operations in Pakistan through its wholly-owned subsidiaries, na …
  • Infinity Turbine LLC:企業の戦略的SWOT分析
    Infinity Turbine LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Novatek (NVTK):企業の財務・戦略的SWOT分析
    Novatek (NVTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Pioneer Corp:企業の戦略的SWOT分析
    Pioneer Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Grohe AG:企業の戦略的SWOT分析
    Grohe AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • IPCA Laboratories Ltd (IPCALAB):企業の財務・戦略的SWOT分析
    Summary IPCA Laboratories Ltd (IPCA) is a manufacturer and supplier of active pharmaceutical ingredients (API’s), generics and branded formulations. It is one of India's largest formulation exporters and is specialized in anti-malarial and anti-bacterials therapeutic segments. The company offers API …
  • PT Bank Bukopin Tbk:企業の戦略・SWOT・財務分析
    PT Bank Bukopin Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bank Bukopin Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Meggitt Training Systems, Inc.:企業の戦略・SWOT・財務分析
    Meggitt Training Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Meggitt Training Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • NanoPass Technologies Ltd:医療機器:M&Aディール及び事業提携情報
    Summary NanoPass Technologies Ltd (NanoPass) is a medical device company that develops and commercializes intradermal delivery solutions for vaccines and drugs. The company's product include MicronJet600 needle, a single use microneedles based device for intradermal delivery. Its micronjet microneed …
  • Biman Bangladesh Airlines Ltd.:企業の戦略・SWOT・財務情報
    Biman Bangladesh Airlines Ltd. - Strategy, SWOT and Corporate Finance Report Summary Biman Bangladesh Airlines Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Mannatech Inc (MTEX):企業の財務・戦略的SWOT分析
    Mannatech Inc (MTEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Australian Pharmaceutical Industries Ltd (API):企業の財務・戦略的SWOT分析
    Australian Pharmaceutical Industries Ltd (API) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Carl Zeiss Meditec AG (AFX):製品パイプライン分析
    Summary Carl Zeiss Meditec AG (Carl Zeiss Meditec), a division of Carl Zeiss AG, an integrated medical technology company which operates in the fields of ophthalmology, neuro/ENT surgery and surgical ophthalmology. It provides comprehensive packages of solutions for the diagnosis and treatment of ey …
  • Celanese Corp (CE):企業の財務・戦略的SWOT分析
    Celanese Corp (CE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Oxford BioTherapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Oxford BioTherapeutics Ltd (OBT) is a clinical stage oncology company that develops antibody drug conjugates for the treatment of variety of cancers. The company’s product pipelines currently includes T-cell based IO therapies including check point modulators; NK cell based IO therapies such …
  • Younicos AG:電力:M&Aディール及び事業提携情報
    Summary Younicos AG (Younicos), a subsidiary of Aggreko Plc, is a provider of smart energy and grid solutions based on battery storage technology. The company offers Y-Cube plug and play energy storage solution, Y-Station building solution, and Y-Q software platform. It also provides battery packs u …
  • Randstad Holding nv:企業の戦略・SWOT・財務情報
    Randstad Holding nv - Strategy, SWOT and Corporate Finance Report Summary Randstad Holding nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • L E Pritchitt & Co Ltd. :企業の戦略・SWOT・財務情報
    L E Pritchitt & Co Ltd. - Strategy, SWOT and Corporate Finance Report Summary L E Pritchitt & Co Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Voya Financial, Inc.:企業の戦略・SWOT・財務情報
    Voya Financial, Inc. - Strategy, SWOT and Corporate Finance Report Summary Voya Financial, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Snam SpA (SRG):石油・ガス:M&Aディール及び事業提携情報
    Summary Snam SpA (Snam) is an integrated midstream energy company. The company, through its subsidiaries, carries out the regasification, transportation, storage and supply of natural gas. It transports and dispatches natural gas through a transportation network, a dispatch center, supervisory distr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆